Citigroup Inc Penumbra Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Penumbra Inc stock. As of the latest transaction made, Citigroup Inc holds 5,681 shares of PEN stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,681

Previous 4,983 14.01%

Holding current value

$1.35 Million

Previous $896,000 23.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.64 - $210.12 $114,220 - $146,663	698 Added 14.01%	5,681 $1.1 Million
Q2 2024 Aug 12, 2024	BUY	$172.27 - $223.95 $238,593 - $310,170	1,385 Added 38.49%	4,983 $896,000
Q1 2024 May 10, 2024	SELL	$220.09 - $273.15 $150,321 - $186,561	-683 Reduced 15.95%	3,598 $803,000
Q4 2023 Feb 09, 2024	SELL	$181.44 - $260.22 $387,011 - $555,049	-2,133 Reduced 33.26%	4,281 $1.08 Million
Q3 2023 Nov 09, 2023	SELL	$240.69 - $338.77 $1.4 Million - $1.97 Million	-5,801 Reduced 47.49%	6,414 $1.55 Million
Q2 2023 Aug 10, 2023	BUY	$271.54 - $344.06 $1.55 Million - $1.97 Million	5,716 Added 87.95%	12,215 $4.2 Million
Q1 2023 May 11, 2023	BUY	$220.43 - $278.69 $335,274 - $423,887	1,521 Added 30.55%	6,499 $1.81 Million
Q4 2022 Feb 09, 2023	SELL	$151.88 - $228.5 $597,192 - $898,462	-3,932 Reduced 44.13%	4,978 $1.11 Million
Q3 2022 Nov 10, 2022	BUY	$120.36 - $205.88 $590,847 - $1.01 Million	4,909 Added 122.69%	8,910 $1.69 Million
Q2 2022 Aug 10, 2022	SELL	$116.09 - $227.33 $113,536 - $222,328	-978 Reduced 19.64%	4,001 $498,000
Q1 2022 May 12, 2022	BUY	$187.51 - $283.98 $287,640 - $435,625	1,534 Added 44.53%	4,979 $1.11 Million
Q4 2021 Feb 10, 2022	BUY	$238.08 - $288.0 $253,555 - $306,720	1,065 Added 44.75%	3,445 $990,000
Q3 2021 Nov 10, 2021	BUY	$250.72 - $291.24 $596,713 - $693,151	2,380 New	2,380 $634,000

Others Institutions Holding PEN

# of Institutions

372

Shares Held

29.1M

Call Options Held

305K

Put Options Held

192K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account